Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Bullboard Posts
Post by AuntiePenny2on Mar 01, 2020 11:32pm
169 Views
Post# 30754351

Remember the dot-com market?

Remember the dot-com market?Stocks would quintuple in an afternoon on stocks that had absolutelly nothing but a dot-com name.It was madness. If corona virus threatens the world economy we will see similar action in vaccine stocks. Several publicly traded vaccine companies have seen their market caps jump by hundreds of millions or even billions last week.

VXL has stated that they are looking for a partner with cash to help exploit VXL's existing technology. If their technology is bona fide - and WHO seems to think it is -  and they find a credible partner this stock will be over $1 in a flash.

Corona virus is a world emergency. China may or may not be almost containing it but Western countries can't use Chinese techniques of containment. Chinese 'medical' staff are going around arresting anybody who has a mild fever. People are being carried naked out of their sick beds, jammed into vans and carted off to quarantine centers. These methods will never work in the US or Europe or other democracies so the sickness will spread.

The death rate is lot higher than 2%. It's more like 5%. Match the deaths against the number of infections 2 weeks earlier because it takes a couple of weeks to kill.
Bullboard Posts